Brief Article Open Access
Copyright copy;2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Oct 21, 2010; 16(39): 4980-4985
Published online Oct 21, 2010. doi: 10.3748/wjg.v16.i39.4980
CABYR RNAi plasmid construction and NF-κB signal transduction pathway
Lin-Xiang Shi, Yao-Ming He, Lin Fang, Hong-Bo Meng, Li-Jun Zheng, Department of General Surgery, Shanghai Tenth People’s Hospital, Tongji University, Shanghai 200072, China
Author contributions: Shi LX and He YM performed the majority of experiments; Fang L provided the vital reagents and financial support for this work; Fang L and He YM designed the study; He YM, Meng HB and Zheng LJ were involved in editing the manuscript and analytical tools.
Supported by Grants from Natural Science Foundation of China, No. 30940034
Correspondence to: Lin Fang, MD, PhD, Department of General Surgery, Shanghai Tenth People’s Hospital, Tongji University, Shanghai 200072, China.
Telephone: +86-21-66301059 Fax: +86-21-66301051
Received: May 1, 2010
Revised: June 10, 2010
Accepted: June 17, 2010
Published online: October 21, 2010


AIM: To construct the CABYR RNAi plasmid and study its relation with the nuclear factor (NF)-κB signal transduction pathway.

METHODS: Human CABYR mRNA sequence was obtained from GenBank. The structure of cDNA sequence for the short hairpin RNA was BbsI + sense + loop + antisense + transcription terminator + KpnI + BamHI. A CABYR silencing plasmid was constructed and transfected into the human embryo cell line 293T. Quantitative real-time polymerase chain reaction was used to analyze CABYR and NF-κB gene expression.

RESULTS: The CABYR and NF-κB expressions were detected in 293T cells. The oligonucleotide (5’-GCTCAGATGTTAGGTAAAG-3’) efficiently silenced the expression of CABYR. The expression of NF-κB was not significantly affected by silencing CABYR (P = 0.743).

CONCLUSION: CABYR can be found in the human embryo cell line 293T. Cabyrmid 2 can efficiently silence its target, CABYR, indicating that CABYR is not related with the NF-κB signal transduction pathway.

Key Words: CABYR, Plasmid, Nuclear factor-κB, Signal transduction, RNAi, Cabyrmid 2


Tumors are the result of multiple genetic mutations in cells. The mutated genes generally affect the signal transduction pathways, inducing changes in the bionomic and hereditary characteristics of tumor cells (TC)[1]. Many abnormalities in various signal transduction pathways of TC have been reported, including the ILK, AP-1, Wnt and nuclear factor (NF)-κB pathways[2,3]. The NF-κB signal transduction pathway is known to enhance the transcription of target gene related to apoptosis, proliferation and differentiation of lymphocytes. Abnormalities in this pathway have been found in many TC. Inhibition of the NF-κB pathway can suppress the growth and metastasis of pancreatic carcinoma, and decrease chemo-drug resistance[2-6]. The NF-κB signaling pathway contains a positive feedback mechanism[7,8] and has crosstalk with other signaling pathways, such as PI3K/AKt[4,9,10], NOTCH1[11], K-ras[12] and Hedgehog[13]. Dysfunction of the NF-κB pathway can contribute to the development of tumors. Some signal transduction pathways related to the phosphorylation of proteins are of the most important regulation mechanism present in cells. CABYR is a calcium-binding tyrosine phosphorylation-regulated protein that has been detected in testis and also in lung cancer[14], and its CR-A and CR-B contain 5 PXXP consensus motifs[15], the cognate sites for SH3 which is one of the signal transduction protein modular binding domains. IκBα molecule, a key regulatory subunit of the NF-κB signal transduction pathway, can be regulated by the PI3K/Akt pathway. CABYR spliceosome III/V can act as an ideal substrate for glycogen synthase kinase-3 (GSK3)β within the extensin-like domain. GSK3β is one of the most important transduction proteins involved in many signal transduction pathways, and plays a vital role in tumorigenesis. We hypothesize that CABYR may be related with the NF-κB signal transduction pathway, affecting basal expression of NF-κB subunit, phosphorylation of IκBα, and DNA binding ability.

Cell culture

Human embryo cell line 293T, obtained from Department of Immunology at Shanghai Tongji University (Shanghai, China), was maintained by passing twice a week in Dulbecco’s modified Eagle’s medium (DMEM; Life Technologies Inc., Gaithesburg, MD, USA) supplemented with 10% fetal bovine serum (FBS), 100 units/mL penicillin and 10 mg/mL streptomycin at 37°C in an atmosphere containing 5% CO2. Each cell line was passed at 70%-80% confluence. The cells were subjected to 6 treatment regimens based on the following groups: CABYR1, CABYR2, CABYR3, empty vector, blank and transfection efficiency reference.

Plasmids and transfection

Human CABYR mRNA sequence was obtained from GenBank (Accession number NM_153768). Three possible target sites to this sequence were chosen with the GenScript SiRNA target finder. BLAST was used to identify whether they are exclusive to CABYR. The target sequences are 5'-CCATCAAACATCAACCAGT-3' (nt 240-258), 5'-GCTCAGATGTTAGGTAAAG-3' (nt 627-645) and 5'-GCTCTCTGACACATCTTT-3' (nt 1256-1273). A short hairpin RNA (shRNA) was designed for use in RNA interference (RNAi) according to the three targets. The TTCAAGAGA sequence is part of the “loop” motif in the shRNA, and the transcription terminator is TTTTT. Restriction endonuclease sites for BbsI, KpnI + BamHI were incorporated into the shRNA sequence, along with a sense and antisense sequence for each cDNA. Single-stranded oligonucleotide DNAs were synthesized by Shanghai Sangon Biological Engineering Technology and Service Company (Shanghai, China). Relative cDNAs are composed of a DNA double strand and a conjunct with pSilence1.0 plasmid. The plasmids were transformed into competent cells and possible transformants were identified, which are resistant to ampicillin. The plasmids were purified using the plasmid minipreps purification system B (BioDev, Beijing, China), then incubated with KpnI to linearise and sequenced to confirm their identity. The 293T cells were transfected with CABYR-shRNA, shRNA control and pEGFP (reference of transfection efficiency) using the Effectene transfection kit (Qiagen, Hilden, Germany). CABYR-shRNA 1, CABYR-shRNA 2 and CABYR-shRNA 3 were designated as Cabyrmid 1, Cabyrmid 2 and Cabyrmid 3, respectively.

Semi-quantitative polymerase chain reaction

The β-actin gene was used as the reference gene when the results were quantified. The primers employed were β-actin (forward: 5'-ACAGAGCCTCGCCTTTGCC-3' and reverse: 5'-CATGTCGTCCCAGTTGGTG-3'), CABYR exon2 (forward: 5'-CAACCCATCAAACATCAACC-3' and reverse: 5'-TGCCATTGCTAACATCTGAG-3'), CABYR exon 4 (forward: 5'-CAGACACAGACGAGGACAATG-3' and reverse: 5'-TCC GTT TGC TCA GTG CCT-3'), NF-κB (forward: 5'-GAGACATCCTTCCGCAAACT-3' and reverse: 5'-TCCTTCCTGCCCATAATCA-3'). Total RNA was extracted from 293T cells using Trizol (Invitrogen, Shanghai, China) following its manufacturer’s instructions, with quality and quantity determined by measuring the optical density at 260 nm and 280 nm. An A260/280 ratio of approximately 1.8 indicated that the RNA sample was of sufficient purity. The RNA integrity was also checked by electrophoresis. Total RNA was reverse transcribed into cDNA using a RevertAid™ cDNA first strand synthesis kit (Fermentas, Ontario, Canada). Thirty cycles of semi-quantitative polymerase chain reaction (PCR) were conducted in a 25 μL volume, with an annealing temperature of 56°C. The PCR products were visualized by agarose gel electrophoresis.

Real-time analysis of gene expression

Changes in NF-κB expression were detected before and after CABYR RNAi treatment by quantitative real-time PCR (qPCR). Total RNA was extracted and reverse transcribed into cDNA using a RevertAid™ cDNA first strand synthesis kit (Fermentas, Ontario, Canada). The primers used in the qPCR are CABYR exon 4 (forward: 5'-CAGACACAGACGAGGACAATG-3' and reverse: 5'-TCCGTTTGCTCAGTGCCT-3'), β-actin (forward: 5'-GCACTCTTCCAGCCTTCCTT-3' and reverse: 5'-GGTCTTTGCGGATGTCCA-3'), NF-κB (forward: 5'-GAGACATCCTTCCGCAAACT-3' and reverse: 5'-TCCTTCCTGCCCATAATCA-3'). cDNA for the blank group was diluted at 1:1, 1:10, 1:100, 1:1000 and 1:10 000 and used in over 40 cycles of two-step qPCR in a 25 μL volume, with an annealing temperature of 62°C. A SYBR Premix Taq kit from Takara Bio (Shiga, Japan) was used. The results were analyzed using the Rotor-gene real-time analysis software.

Statistical analysis

All the experiments were repeated three times and the results were analyzed using SPSS 13.0 (SPSS Inc., Chicago, IL, USA). The statistical analytical method was one-way ANOVAD. P < 0.05 was considered statistically significant.

Basal expression of CABYR and NF-κB mRNA in 293T cells

The transcripts of CABYR and NF-κB were detected in 293T cells (Figure 1).

Figure 1
Figure 1 Basic expression of CABYR (A) and nuclear factor-κB (B) at mRNA level in 293T cells. Total RNA was extracted from 293T cells with Trizol and reverse transcribed to 293T cDNA with the primer Oligo(dt). The target fragment was amplified by semi-quantitative polymerase chain reaction and analyzed by agarose electrophoresis (1%). CABYR and nuclear factor (NF)-κB were detectable in 293T cells, indicating that 293T cells can be used to identify the efficient silence fragment for CABYR and study the relation between CABYR and NF-κB. 1: β-actin; 2: CABYR; 3: NF-κB; M: Marker.
Construction of CABYR shRNA eukaryotic expression vector

The gene fragment was inserted between the restriction sites of BbsI and BamHI in pSlience1.0 (Figure 2). The plasmid also contained a restriction site of KpnI, and a KpnI recognition sequence was incorporated into the ends of our gene fragment. Possible recombinant plasmids were identified by digesting with the appropriate restriction endonuclease and a 396-397 bp product would be liberated if the target fragment was correctly incorporated (Figure 3). The identified recombinant plasmids were sequenced by Shanghai Sangon Company for further verification (Figure 4).

Figure 2
Figure 2 Construction of CABYR shRNA eucaryon expression vector by inserting the target gene fragment into pSlience1. 0 (3.23 kb) between BbsI and BamHI.
Figure 3
Figure 3 Construction of CABYR shRNA eucaryon expression vector by inserting the target fragment we constructed into the RNAi plasmid. 1:vacant vector; 2: Cabyrmid 1 vector; 3: Cabyrmid 2 vector; 4: Cabyrmid 3 vector; M1: Marker 1; M2: Marker 2.
Figure 4
Figure 4 Construction of CABYR shRNA eucaryon expression vector by locating shRNA in plasmid.
CABYR shRNA expression in different groups

GFP was highly expressed in the reference group, indicating that a high efficiency of transfection can be achieved in the other groups under the same conditions (Figure 5). CABYR mRNA was also expressed in the blank control, vacant vector control and CABYR RNAi groups. The CABYR mRNA expression was decreased in CABYR RNAi group, indicating that 5'-GCTCAGATGTTAGGTAAAG-3' is an efficient silencing target for CABYR (Figure 6).

Figure 5
Figure 5 CABYR shRNA expression in reference group (A) and CABYR mRNA expression in other groups (B). A: HE stain, × 100; B: Blue fluorescent, ×100.
Figure 6
Figure 6 CABYR mRNA expressions in different groups after transfection. M: Marker; 1: Cabyrmid 1; 2: Cabyrmid 2; 3: Cabyrmid 3; P: Vacant vector; B: Blank.
Relation between CABYR and NF-κB signal pathway

According to the standard curve generated, CT exhibited a strong linear correlation between CABYR and NF-κB at different diluted concentrations, thus the precise results could be obtained using qPCR. The M value for β-actin, CABYR and NF-κB was approximately uniform, indicating that their amplification efficiency is similar. The concentration of target fragment was analyzed using the ∆(∆CT) method. The results showed that the mRNA expression was obviously decreased in the siRNA2 group, indicating that 5'-GCTCAGATGTTAGGTAAAG-3' can silence the expression of CABYR mRNA transcript, while the expression of NF-κB was not affected by silencing CABYR (P = 0.743), displaying that CABYR has no significant effect on the expression of NF-κB (Table 1).

Table 1 Relation between CABYR and nuclear factor-κB signal pathway (mean ± SD).
GroupCABYR [Δ(ΔCT) value]NF-κB [Δ(ΔCT) value]
Control group-0.06 ± 0.18-0.38 ± 0.51
Cabyrmid 10.19 ± 0.23-0.10 ± 0.25
Cabyrmid 22.11 ± 0.15a-0.05 ± 0.79
Cabyrmid 30.76 ± 0.33-0.15 ± 0.20
F value51.9280.381

In this study, a CABYR silencing plasmid was constructed with its function observed. CABYR, first identified in the testis by Naaby-Hansen et al[16], plays a key role in protein tyrosine phosphorylation and increases the concentration of intracellular calcium. Its transcript variants encode multiple protein isoforms, but spliceosome III/V is not specific for testis[15]. CABYR can be found in pancreas, fetal brain, liver, motile cilia of human bronchus and fallopian tubes[17]. In this study, CABYR was identified in the human embryo cell line 293T.

Cabyrmid 2 is an effective CABYR silencing plasmid. In this study, 3 target fragments of CABYR were designed using the GenScript SiRNA target finder and compared with the corresponding sequences in GenBank to determine its specificity[18]. The CABYR shRNA we constructed, inserted downstream from the strong U6 promoter in pSilence 1.0 and transcribed, which became a functional siRNA with an ability to degrade CABYR mRNA exclusively. The effective CABYR shRNA was screened by transfecting 293T cells via lipofection as previously described[19,20]. In this study, a highly effective CABYR silencing site, 5'-GCTCAGATGTTAGGTAAAG-3', was found, and a short hairpin plasmid that could effectively silence CABYR expression was constructed, which was designated as Cabyrmid 2.

The expression or repression of CABYR had no effect on NF-κB signaling pathways in our study. It has been shown that CABYR spliceosome III/V can act as an ideal substrate for GSK3β in the extensin-like domain[21]. GSK3β is known to play a key role in tumorigenesis[22-26] in conjunction with PI3K/Akt which plays a role in the regulation of the NF-κB transduction pathway. NF-κB plays an important role in embryo growth, differentiation and apoptosis of lymphocytes, immunological and inflammatory reactions[27-31]. Abnormal CABYR and NF-κB have been detected in the same cancers, and CABYR possesses a tyrosine kinase activity which is an important kinase in various signaling pathways, suggesting that CABYR may be related with NF-κB. However, no significant effect of CABYR was observed on the expression of NF-κB in this study.

Two reasons can explain why CABYR had no significant effect on the expression of NF-κB in this study. One is that the 293T cells were used while the NF-κB signaling pathway was normal. If their relation was detected in Bxpc3 (NF-κB dysfunction), other results may be observed. The other is that NF-κB exists as an inactive precursor (p50, p60, IκBα) in cytoplasm. After NF-κB is activated, IκBα is phosphorylated and detached from the conglomeration. The remaining molecules enter the nuclei and adhere to target DNA, thereby enhancing transcription. Phosphorylation of IκBα is a key step in the NF-κB pathway. Though no significant effect of CABYR was observed on the expression of NF-κB in this study, CABYR possesses a tyrosine kinase activity possibly affecting the NF-κB pathway by phosphorylating IκBα. It has been reported that G3BP2 (RasGAP SH3-binding protein 2) is able to discriminate between amino terminals of IκBα[32] related with the retention of IκBα/NF-κB conglomeration in cytoplasm. CABYR also contains a PXXP motif, similar to G3BP2 which is a core part of the SH3 aglucone. A study involving the influenza A virus demonstrated that the structure of SH3 plays a key role in determining the activity of PI3K/Akt[33]. The PI3K/Akt signaling pathway can also regulate the phosphorylation of IκBα, indicating that CABYR may take part in the regulation of the NF-κB signaling pathway.

In summary, CABYR is not exclusive to the testis and codes for a calcium-binding tyrosine-phosphorylation regulated protein that is intimately involved in calcium signaling. Cabyrmid 2 can efficiently silence CABYR expression rather than the expression of NF-κB in 293T cells.


Tumor is a polygene mutation disease. The mutation gene effects on the signal transduction pathway inducing tumor cell’s (TC). Many abnormalities of signal transduction pathway in TC have been reported, such as ILK, AP-1, Wnt, and nuclear factor (NF)-κB. Recently NF-κB signal transduction pathway was hotly researched. It can enhance the transcription of the target gene relating to the apoptosis, proliferation and differentiation of lymphocyte. And its abnormality was also been found in many TC. CABYR is an capacitation related calcium binding tyrosine-(Y)-phosphorylation regulated gene, it has no absolute testis specificity, it was also reported that CABYR antigen was detected in many cancers such as lung cancer.

Research frontiers

NF-κB signal transduction pathway can enhance the transcription of the target gene relating to the apoptosis, proliferation, and differentiation of lymphocyte etc. The inhibition of NF-κB can depress growth and metastasis of pancreatic carcinoma, and decrease the chemo-drug resistance. NF-κB signal transduction pathway has many crosstalk with other signal pathway. This indicated that the dysfunction of NF-κB signal pathway contribute an important part of tumors development. CABYR is an capacitation related calcium binding tyrosine-(Y)-phosphorylation regulated gene. its CR-A and CR-B contain five PXXP consensus motifs, the cognate sites for SH3 ,one of the signal transduction protein Modular Binding Domains, interaction. On another side IκBα, the key regulated subunit of NF-κB signal transduction pathway, can been regulated by the PI3K/Akt signal pathway. CABYR splicesome III/V act as an ideal substrate for GSK3beta (glycogen synthase kinase-3) within the extensin-like domain. The GSK3beta is one of the most important transduction proteins involving in many signal transduction pathway which play a key role in tumorous genesis and development including PI3K/Akt signal pathway. So the authors hypothesised that CABYR may have some relationship with NF-κB signal transduction pathway.

Innovations and breakthroughs

The authors constructed CABYR silence plasmid (Cabyrmid 2) and proved that CABYR RNAi plasmid 2 is the efficient silence target to CABYR. They also found that CABYR may have no relationship with NF-κB signal transduction pathway.


CABYR silence plasmid (Cabyrmid 2) may help the authors in the future research of CABYR.


CABYR is a calcium binding tyrosine phosphorylation regulator gene. It was first found in testis by Naaby-Hansen in 2002. CABYR plays a key role in capacitation involving protein tyrosine phosphorylation and increased intracellular calcium. Transcript variants of this gene encode multiple protein isoforms. And its spliceosome III/V wasn’t seem to be absolute testis specificity. It also be found in the pancreatic tissue, fetal brain, sclerosis liver as well.

Peer review

The authors have presented a basic study with convincing data. It will be suitable for publication after revision.


Peer reviewer: Thomas Bock, PhD, Professor, Department of Molecular Pathology, Institute of Pathology, University Hospital of Tuebingen, D-72076 Tuebingen, Germany

S- Editor Wang YR L- Editor Wang XL E- Editor Ma WH

1.  Adjei AA, Hidalgo M. Intracellular signal transduction pathway proteins as targets for cancer therapy. J Clin Oncol. 2005;23:5386-5403.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Fahy BN, Schlieman MG, Virudachalam S, Bold RJ. Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancer. J Am Coll Surg. 2004;198:591-599.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Xiong HQ, Abbruzzese JL, Lin E, Wang L, Zheng L, Xie K. NF-kappaB activity blockade impairs the angiogenic potential of human pancreatic cancer cells. Int J Cancer. 2004;108:181-188.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Kim D, Dan HC, Park S, Yang L, Liu Q, Kaneko S, Ning J, He L, Yang H, Sun M. AKT/PKB signaling mechanisms in cancer and chemoresistance. Front Biosci. 2005;10:975-987.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Fahy BN, Schlieman MG, Mortenson MM, Virudachalam S, Bold RJ. Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib. Cancer Chemother Pharmacol. 2005;56:46-54.  [PubMed]  [DOI]  [Cited in This Article: ]
6.  Banerjee S, Zhang Y, Wang Z, Che M, Chiao PJ, Abbruzzese JL, Sarkar FH. In vitro and in vivo molecular evidence of genistein action in augmenting the efficacy of cisplatin in pancreatic cancer. Int J Cancer. 2007;120:906-917.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Kwon G, Corbett JA, Rodi CP, Sullivan P, McDaniel ML. Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism. Endocrinology. 1995;136:4790-4795.  [PubMed]  [DOI]  [Cited in This Article: ]
8.  Niu J, Li Z, Peng B, Chiao PJ. Identification of an autoregulatory feedback pathway involving interleukin-1alpha in induction of constitutive NF-kappaB activation in pancreatic cancer cells. J Biol Chem. 2004;279:16452-16462.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Shah SA, Potter MW, Hedeshian MH, Kim RD, Chari RS, Callery MP. PI-3’ kinase and NF-kappaB cross-signaling in human pancreatic cancer cells. J Gastrointest Surg. 2001;5:603-612; discussion 612-613.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Schlieman MG, Fahy BN, Ramsamooj R, Beckett L, Bold RJ. Incidence, mechanism and prognostic value of activated AKT in pancreas cancer. Br J Cancer. 2003;89:2110-2115.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Wang Z, Zhang Y, Banerjee S, Li Y, Sarkar FH. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells. Cancer. 2006;106:2503-2513.  [PubMed]  [DOI]  [Cited in This Article: ]
12.  Saleem M, Kaur S, Kweon MH, Adhami VM, Afaq F, Mukhtar H. Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway. Carcinogenesis. 2005;26:1956-1964.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Nakashima H, Nakamura M, Yamaguchi H, Yamanaka N, Akiyoshi T, Koga K, Yamaguchi K, Tsuneyoshi M, Tanaka M, Katano M. Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer. Cancer Res. 2006;66:7041-7049.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Luo C, Xiao X, Liu D, Chen S, Li M, Xu A, Liu J, Gao S, Wu S, He D. CABYR is a novel cancer-testis antigen in lung cancer. Clin Cancer Res. 2007;13:1288-1297.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Hsu HC, Lee YL, Cheng TS, Howng SL, Chang LK, Lu PJ, Hong YR. Characterization of two non-testis-specific CABYR variants that bind to GSK3beta with a proline-rich extensin-like domain. Biochem Biophys Res Commun. 2005;329:1108-1117.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Naaby-Hansen S, Mandal A, Wolkowicz MJ, Sen B, Westbrook VA, Shetty J, Coonrod SA, Klotz KL, Kim YH, Bush LA. CABYR, a novel calcium-binding tyrosine phosphorylation-regulated fibrous sheath protein involved in capacitation. Dev Biol. 2002;242:236-254.  [PubMed]  [DOI]  [Cited in This Article: ]
17.  Newell AE, Fiedler SE, Ruan JM, Pan J, Wang PJ, Deininger J, Corless CL, Carr DW. Protein kinase A RII-like (R2D2) proteins exhibit differential localization and AKAP interaction. Cell Motil Cytoskeleton. 2008;65:539-552.  [PubMed]  [DOI]  [Cited in This Article: ]
18.  Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science. 2002;296:550-553.  [PubMed]  [DOI]  [Cited in This Article: ]
19.  Li CX, Parker A, Menocal E, Xiang S, Borodyansky L, Fruehauf JH. Delivery of RNA interference. Cell Cycle. 2006;5:2103-2109.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Putnam D, Doody A. RNA-interference effectors and their delivery. Crit Rev Ther Drug Carrier Syst. 2006;23:137-164.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Sen B, Mandal A, Wolkowicz MJ, Kim YH, Reddi PP, Shetty J, Bush LA, Flickinger CJ, Herr JC. Splicing in murine CABYR and its genomic structure. Gene. 2003;310:67-78.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. RNA interference demonstrates a novel role for integrin-linked kinase as a determinant of pancreatic adenocarcinoma cell gemcitabine chemoresistance. Clin Cancer Res. 2005;11:3433-3438.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Yau CY, Wheeler JJ, Sutton KL, Hedley DW. Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xenografts. Cancer Res. 2005;65:1497-1504.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Sclabas GM, Fujioka S, Schmidt C, Li Z, Frederick WA, Yang W, Yokoi K, Evans DB, Abbruzzese JL, Hess KR. Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells. Clin Cancer Res. 2005;11:440-449.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Chetty R, Serra S, Salahshor S, Alsaad K, Shih W, Blaszyk H, Woodgett JR, Tsao MS. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis. Hum Pathol. 2006;37:212-217.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Summy JM, Trevino JG, Baker CH, Gallick GE. c-Src regulates constitutive and EGF-mediated VEGF expression in pancreatic tumor cells through activation of phosphatidyl inositol-3 kinase and p38 MAPK. Pancreas. 2005;31:263-274.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Bladh LG, Johansson-Haque K, Rafter I, Nilsson S, Okret S. Inhibition of extracellular signal-regulated kinase (ERK) signaling participates in repression of nuclear factor (NF)-kappaB activity by glucocorticoids. Biochim Biophys Acta. 2009;1793:439-446.  [PubMed]  [DOI]  [Cited in This Article: ]
28.  Liu H, Yang H, Wang D, Liu Y, Liu X, Li Y, Xie L, Wang G. Insulin regulates P-glycoprotein in rat brain microvessel endothelial cells via an insulin receptor-mediated PKC/NF-kappaB pathway but not a PI3K/Akt pathway. Eur J Pharmacol. 2009;602:277-282.  [PubMed]  [DOI]  [Cited in This Article: ]
29.  Pal A, Bhattacharya I, Bhattacharya K, Mandal C, Ray M. Methylglyoxal induced activation of murine peritoneal macrophages and surface markers of T lymphocytes in sarcoma-180 bearing mice: involvement of MAP kinase, NF-kappa beta signal transduction pathway. Mol Immunol. 2009;46:2039-2044.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Shant J, Cheng K, Marasa BS, Wang JY, Raufman JP. Akt-dependent NF-kappaB activation is required for bile acids to rescue colon cancer cells from stress-induced apoptosis. Exp Cell Res. 2009;315:432-450.  [PubMed]  [DOI]  [Cited in This Article: ]
31.  Rusu D, Drouin R, Pouliot Y, Gauthier S, Poubelle PE. A bovine whey protein extract stimulates human neutrophils to generate bioactive IL-1Ra through a NF-kappaB- and MAPK-dependent mechanism. J Nutr. 2010;140:382-391.  [PubMed]  [DOI]  [Cited in This Article: ]
32.  Prigent M, Barlat I, Langen H, Dargemont C. IkappaBalpha and IkappaBalpha /NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2. J Biol Chem. 2000;275:36441-36449.  [PubMed]  [DOI]  [Cited in This Article: ]
33.  Shin YK, Li Y, Liu Q, Anderson DH, Babiuk LA, Zhou Y. SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation. J Virol. 2007;81:12730-12739.  [PubMed]  [DOI]  [Cited in This Article: ]